 |
Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic.
NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End Smoking is pleased to announce the appointment of Nataliia "Natasha" Toropova as its new Chief Development Officer, effective immediately.
"I'm honored to join Global Action, an organization that shares my own values of compassion for those who smoke and my vision of a world without smoking-related deaths," said Toropova.
Natasha will lead Global Action's efforts to expand its philanthropic reach by funding critical research and initiatives that accelerate progress toward ending smoking worldwide. She brings decades of experience in public health, tobacco control, and fundraising including as a Programme Manager for the World Health Organization (WHO) and as an Advocacy Coordinator at Campaign for Tobacco Free Kids in Eastern Europe. In these roles, she not only promoted public health initiatives but also led successful fundraising campaigns to support their missions.
Most recently, Natasha completed her six-year tenure as CEO of Healthy Initiatives, a nonprofit organization committed to strengthening public health by addressing the risk of non-communicable diseases in countries including Ukraine, Eastern Europe, and Central Asia. As a grantee of Global Action, Healthy Initiatives has educated hundreds of health care providers across nine countries in Eastern Europe and Central Asia on the benefits of tobacco harm reduction for people who cannot or will not quit smoking—especially amid the stress of global conflict. The team has also provided critical aid—including CAT tourniquets, ambulances, and mental health support—to the areas most impacted by the ongoing war in Ukraine.
"Natasha brings a bold vision, deep expertise, and an unwavering commitment to public health," said Pam Parizek, Executive Board Chair of Global Action. "She's seen firsthand the positive impact Global Action's support can have to accelerate smoking cessation, and is the perfect person to lead our efforts to secure additional funding for this life-saving work."
Natasha joins Global Action at a pivotal time as the organization reinvigorates its commitment to grantees. Through a recent reorganization, Global Action has ensured its ability to exist until its mission to end smoking is completed, allowing it to honor existing commitments and fund future grants. Natasha's development work will directly support Global Action's grantees, which currently include projects with organizations such as Northwell Health, the National Harm Reduction Coalition and ECLAT, a research-based spinoff of the University of Catania. She will work closely with the executive leadership team to carry out her fundraising and outreach duties.
"Global Action remains steadfast in its commitment to its mission," said Heidi Goldstein, President and Chief Legal Officer of Global Action. "We have now guaranteed that our organization will last to see the end of the global smoking epidemic."
About Global Action to End Smoking
Global Action to End Smoking is an independent U.S. nonprofit 501(c)(3) grantmaking organization whose charitable mission is to end combustible tobacco use, which remains the leading preventable cause of death globally. Historically, Global Action received funding from PMI Global Services, Inc. (PMI). As of September 2023, Global Action and PMI terminated their original funding agreement, and Global Action formally adopted a policy not to seek or accept funding from companies that produce tobacco or non-medicinal nicotine products.
Media Contact:
Katherine Ellen Foley
202-215-9971
Katherine.Foley@actiontoendsmoking.org
Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic.
NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End Smoking is pleased to announce the appointment of Nataliia "Natasha" Toropova as its new Chief Development Officer, effective immediately.
"I'm honored to join Global Action, an organization that shares my own values of compassion for those who smoke and my vision of a world without smoking-related deaths," said Toropova.
Natasha will lead Global Action's efforts to expand its philanthropic reach by funding critical research and initiatives that accelerate progress toward ending smoking worldwide. She brings decades of experience in public health, tobacco control, and fundraising including as a Programme Manager for the World Health Organization (WHO) and as an Advocacy Coordinator at Campaign for Tobacco Free Kids in Eastern Europe. In these roles, she not only promoted public health initiatives but also led successful fundraising campaigns to support their missions.
Most recently, Natasha completed her six-year tenure as CEO of Healthy Initiatives, a nonprofit organization committed to strengthening public health by addressing the risk of non-communicable diseases in countries including Ukraine, Eastern Europe, and Central Asia. As a grantee of Global Action, Healthy Initiatives has educated hundreds of health care providers across nine countries in Eastern Europe and Central Asia on the benefits of tobacco harm reduction for people who cannot or will not quit smoking—especially amid the stress of global conflict. The team has also provided critical aid—including CAT tourniquets, ambulances, and mental health support—to the areas most impacted by the ongoing war in Ukraine.
"Natasha brings a bold vision, deep expertise, and an unwavering commitment to public health," said Pam Parizek, Executive Board Chair of Global Action. "She's seen firsthand the positive impact Global Action's support can have to accelerate smoking cessation, and is the perfect person to lead our efforts to secure additional funding for this life-saving work."
Natasha joins Global Action at a pivotal time as the organization reinvigorates its commitment to grantees. Through a recent reorganization, Global Action has ensured its ability to exist until its mission to end smoking is completed, allowing it to honor existing commitments and fund future grants. Natasha's development work will directly support Global Action's grantees, which currently include projects with organizations such as Northwell Health, the National Harm Reduction Coalition and ECLAT, a research-based spinoff of the University of Catania. She will work closely with the executive leadership team to carry out her fundraising and outreach duties.
"Global Action remains steadfast in its commitment to its mission," said Heidi Goldstein, President and Chief Legal Officer of Global Action. "We have now guaranteed that our organization will last to see the end of the global smoking epidemic."
About Global Action to End Smoking
Global Action to End Smoking is an independent U.S. nonprofit 501(c)(3) grantmaking organization whose charitable mission is to end combustible tobacco use, which remains the leading preventable cause of death globally. Historically, Global Action received funding from PMI Global Services, Inc. (PMI). As of September 2023, Global Action and PMI terminated their original funding agreement, and Global Action formally adopted a policy not to seek or accept funding from companies that produce tobacco or non-medicinal nicotine products.
Media Contact:
Katherine Ellen Foley
202-215-9971
Katherine.Foley@actiontoendsmoking.org
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer
– Operations in 80+ countries with over 45,000 installed platforms and 66% international revenue mix
– Consumables account for 46% of revenue, with more than 5.5 million HIFU procedures performed annually worldwide
– Accelerating growth through two strategic M&A transactions over the past two years
SEOUL, South Korea, April 30, 2026 /PRNewswire/ -- Classys Inc. (KOSDAQ: 214150), a global medical aesthetics platform company, has released its latest Annual Report, outlining its global installed base and scalable business model.
The company operates in more than 80 countries and has built a cumulative installed base of over 45,000 systems, supported by a high-margin, consumables-driven revenue structure.
The global medical aesthetics market continues to be driven by strong demand for injectable procedures led by companies such as Galderma. At the same time, energy-based devices (EBD) are gaining increasing attention as providers and patients seek solutions that support more natural-looking outcomes.
Against this backdrop, Classys has developed a differentiated portfolio of energy-based technologies, positioning the company to address evolving market demand.
Looking ahead, 2026 is expected to be a pivotal year for Classys, with strong earnings visibility. The company has provided revenue guidance of approximately KRW 490 billion, representing 45% year-over-year growth. This outlook reflects expanding direct operations in Japan and Brazil, increasing adoption across Europe and the United States, and continued growth of its monopolar RF platform, Everesse (Volnewmer).
Classys is also advancing its global go-to-market strategy by transitioning from a distributor-based model to direct operations in key markets. This shift is expected to enhance brand control, strengthen customer engagement, and support higher consumables penetration.
The company is progressing regulatory approval in China, which would complete its presence across the three largest global medical aesthetics markets: the United States, Europe, and China. Industry participants view this as a key inflection point for long-term growth.
To support its expansion, Classys has executed strategic M&A, including the acquisition of Ilooda to expand its product portfolio and a Brazilian distributor to strengthen its global distribution network.
Through this strategy, Classys has established a scalable platform business model that combines high growth (30%+ CAGR) and high profitability (50%+ operating margin), reinforcing its long-term growth trajectory through 2030.
View Full Article: https://www.prnewswire.com/news-releases/classys-emerges-as-a-global-leader-in-medical-aesthetics-beyond-k-beauty-highlighting-45-growth-50-margins-and-recurring-revenue-model-302752605.html
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Classys Emerges as a Global Leader in Medical Aesthetics Beyond K-Beauty, Highlighting 45% Growth, 50%+ Margins, and Recurring Revenue Model
